Authors
Latest:
Recognize the Value of Health Care VolunteersThe health care industry must cultivate volunteer support to maintain a positive impact on vaccination rates.
Latest:
Evaluation of a Pharmacy-Delivered Oncofertility InterventionThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Interprofessional Education in Medical School Creates a Collaborative EnvironmentAdaptability, teamwork, and a culture of lifetime learning are required virtues in our rapidly evolving medical landscape.
Latest:
Navigating the Rapid Growth of Specialty Drugs: Opportunities, Challenges, and the Path AheadHigh-cost novel therapies challenge payers and patients, while biosimilars help balance affordability.
Latest:
The Future of Cancer Drug Development: Advancements, Challenges, and the Transformative Role of AIAI is revolutionizing oncology drug development, enhancing therapeutic identification and reducing approval times, but use of this tool must be carefully implemented to mitigate risks and ensure regulatory compliance.
Latest:
It Is Time to Consider Alternatives to Discipline ProgramsProfessional assistance programs provide pathway for health care professionals to return to practice following treatment for substance use disorder.
Latest:
What Drug Rates Are Reported in Price Transparency Data?It is valuable for pharmacists to understand exactly how price transparency data are sourced, what information can be found, antitrust concerns, and implications for the pharmaceutical industry.
Latest:
Understanding Pharmacogenomics Is Essential for Personalized CarePharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
Latest:
Bacteroidetes: The Jekyll and Hyde of the Human Gut MicrobiomeThe relative abundance of gram-negative Bacteroidetes to other phyla, such as gram-positive Firmicutes, is essential to maintain biodiversity and human gut health.
Latest:
Therapies Under Investigation for Waldenström MacroglobulinemiaThe exciting therapies in the pipeline that are thought to target novel mechanisms in Waldenström macroglobulinemia.
Latest:
Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical ConsiderationsThis article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Latest:
Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating FactorThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
ASCO 2025: Real-World Data Support Rechallenging Trastuzumab Deruxtecan After ILDHope Rugo, MD, discusses a multi-institutional real-world analysis showing that rechallenging trastuzumab deruxtecan after grade 1 interstitial lung disease (ILD) is generally safe and effective.
Latest:
Insights on the UK's MHRA International Recognition ProcedureThe UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Latest:
Expert: Pharmacists Play Critical Role in Vaccination, Public Health Amid Ongoing Viral RisksPharmacists have been central to vaccine distribution since the COVID-19 pandemic, and as viruses spread, they must continue urging patients to stay updated on vaccinations to prevent severe illness and reduce hospitalizations.
Latest:
New Frontiers in Technology: AI Use in Clinical Trial Patient Recruitment in Health SystemsAI is significantly enhancing the efficiency of identifying and enrolling patients.
Latest:
Long Story Short: Cellulitis Can Be Treated in Less Than a WeekDuration of therapy may be just 5 to 6 days for patients without risk factors for complications.
Latest:
HER2 and HER3 in NSCLC: The Latest ADC Data and NCCN Guideline UpdatesCorrine Stahura, PharmD, and Sophia Gilardone, PharmD, BCOP, discuss recent clinical trial data and evolving guideline recommendations for HER2- and HER3-directed antibody-drug conjugates (ADCs) in non–small cell lung cancer (NSCLC), highlighting differences in efficacy, safety, and patient selection criteria.
Latest:
One Year Later: Key Issues Impacting Health System Pharmacies During the COVID-19 Vaccine RolloutThis vaccine rollout has become even more crucial for the US health care system, as new mutations of the coronavirus continue to emerge.
Latest:
Student Advocacy in PharmacyStudent pharmacists can work toward a better future for patients, themselves, and the profession.
Latest:
Fellowship Focus: Elevating Pediatric Medication Safety Through Data, AI, and CollaborationOchsner Children’s Hospital, in partnership with ISMP, has launched a fellowship to advance pediatric medication safety through hands-on training in key competencies, national safety strategies, interdisciplinary collaboration, and innovative tools such as AI and data dashboards.
Latest:
Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori InfectionFor pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.
Latest:
How Data Can Help Demonstrate the Value of the Health-System Specialty PharmacyInsurers, accountable care organizations, and manufacturers increasingly look for demonstrable clinical outcomes as proof for reimbursement or access to limited distribution networks.
Latest:
As Shortages Continue, Suppliers, Hospitals, and Health Systems Look for New SolutionsHospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.
Latest:
Asembia AXS25: Digital Pharmacy Strategies for Patient-Centered CareDigital pharmacy solutions are revolutionizing patient care.
Latest:
Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy SettingsAlthough pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.
Latest:
Integration of Palliative Pharmacists to Elevate Oncologic CarePalliative pharmacists are invaluable assets of oncologic care.
